Found: 111
Select item for more details and to access through your institution.
Vitamin D and HPV infection: Clinical pearls.
- Published in:
- Journal of Cosmetic Dermatology, 2024, v. 23, n. 7, p. 2509, doi. 10.1111/jocd.16280
- By:
- Publication type:
- Article
Investigating the impact of added Profhilo mesogel to subcision versus subcision monotherapy in treating acne scars; a single‐blinded, split‐face randomized trial.
- Published in:
- Journal of Cosmetic Dermatology, 2024, v. 23, n. 6, p. 1992, doi. 10.1111/jocd.16258
- By:
- Publication type:
- Article
Comparison of efficacy and safety of tretinoin 0.05% and glycolic acid peeling 70% in axillary and neck lesions of acanthosis nigricans: A single‐blinded, randomized trial.
- Published in:
- Journal of Cosmetic Dermatology, 2024, v. 23, n. 6, p. 2090, doi. 10.1111/jocd.16224
- By:
- Publication type:
- Article
A case of IgA pemphigus, with a poor response to dapsone, successfully treated with adalimumab.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Rituximab as a maintenance treatment in patients with pemphigus vulgaris: When is the right time for discontinuation?
- Published in:
- Journal of Cosmetic Dermatology, 2024, v. 23, n. 2, p. 406, doi. 10.1111/jocd.16030
- By:
- Publication type:
- Article
Treatment Resistance to TNF-α Inhibitors in Patients with Psoriasis.
- Published in:
- Dermatologic Therapy, 2023, p. 1, doi. 10.1155/2023/7399468
- By:
- Publication type:
- Article
Association of alternative healthy eating index and severity of pemphigus vulgaris: A cross-sectional study.
- Published in:
- PLoS ONE, 2023, v. 18, n. 12, p. 1, doi. 10.1371/journal.pone.0295026
- By:
- Publication type:
- Article
A case report of esophageal cancer in a patient with pemphigus vulgaris: A coincidence or something beyond that?
- Published in:
- Cancer Reports, 2023, v. 6, n. 12, p. 1, doi. 10.1002/cnr2.1896
- By:
- Publication type:
- Article
Two cases of neglected leishmaniasis with marked facial disfigurement: A diagnostic conundrum.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Combination therapy for management of pemphigus patients with unexpected therapeutic response to rituximab: A report of five cases.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
COVID outcome in pemphigus: Does rituximab make pemphigus patients susceptible to more severe COVID‐19?
- Published in:
- Journal of Cosmetic Dermatology, 2023, v. 22, n. 11, p. 2880, doi. 10.1111/jocd.15958
- By:
- Publication type:
- Article
ODSS vs. ABSIS and PDAI oral parts in pemphigus vulgaris: inter‐rater reliability and testing times.
- Published in:
- Oral Diseases, 2023, v. 29, n. 7, p. 2696, doi. 10.1111/odi.14320
- By:
- Publication type:
- Article
The impact of the COVID‐19 pandemic on the diagnosis and treatment of skin cancers, a mini review.
- Published in:
- Cancer Reports, 2023, v. 6, n. 9, p. 1, doi. 10.1002/cnr2.1854
- By:
- Publication type:
- Article
Isotretinoin and timing of procedural interventions: Clinical implications and practical points.
- Published in:
- Journal of Cosmetic Dermatology, 2023, v. 22, n. 8, p. 2146, doi. 10.1111/jocd.15874
- By:
- Publication type:
- Article
Rituximab zur Behandlung von Epidermolysis bullosa acquisita: Eine große Fallserie mit 15 Patienten.
- Published in:
- Journal der Deutschen Dermatologischen Gesellschaft, 2023, v. 21, n. 7, p. 779, doi. 10.1111/ddg.15108_g
- By:
- Publication type:
- Article
Rituximab for the treatment of epidermolysis bullosa acquisita: A large case series of 15 patients.
- Published in:
- Journal der Deutschen Dermatologischen Gesellschaft, 2023, v. 21, n. 7, p. 779, doi. 10.1111/ddg.15108
- By:
- Publication type:
- Article
Factors associated with the healing time of pemphigus vulgaris oral lesions: A prospective study.
- Published in:
- Oral Diseases, 2023, v. 29, n. 5, p. 2248, doi. 10.1111/odi.14236
- By:
- Publication type:
- Article
Nail abnormalities in subepidermal blistering diseases: a cross‐sectional study.
- Published in:
- International Journal of Dermatology, 2023, v. 62, n. 6, p. 783, doi. 10.1111/ijd.16624
- By:
- Publication type:
- Article
Serologic Biomarkers in Pemphigus Monitoring: C-reactive Protein, Macrophage Migration Inhibitory Factor, and Prolactin Levels Versus Autoantibody Assays.
- Published in:
- Iranian Journal of Allergy, Asthma & Immunology, 2023, v. 22, n. 3, p. 312, doi. 10.18502/ijaai.v22i3.13059
- By:
- Publication type:
- Article
Anatomic evaluation of the normal variants of the arteries of face using color Doppler ultrasonography: Implications for facial aesthetic procedures.
- Published in:
- Journal of Cosmetic Dermatology, 2023, v. 22, n. 6, p. 1844, doi. 10.1111/jocd.15646
- By:
- Publication type:
- Article
Kaposi's sarcoma in a patient with pemphigus vulgaris mimicking exacerbation of pemphigus.
- Published in:
- Cancer Reports, 2023, v. 6, n. 5, p. 1, doi. 10.1002/cnr2.1815
- By:
- Publication type:
- Article
Elevated serum level of B‐cell activating factor (BAFF) after rituximab therapy in pemphigus vulgaris patients suggests a possible therapeutic efficacy of B‐cell depletion therapies combined with anti‐BAFF agents.
- Published in:
- International Journal of Dermatology, 2023, v. 62, n. 4, p. 567, doi. 10.1111/ijd.16363
- By:
- Publication type:
- Article
Various aspects of the relationship between vitiligo and the COVID‐19 pandemic or SARS‐CoV‐2 vaccines: Clinical pearls for dermatologists.
- Published in:
- Journal of Cosmetic Dermatology, 2023, v. 22, n. 4, p. 1152, doi. 10.1111/jocd.15550
- By:
- Publication type:
- Article
Rituximab Treatment and Improvement of Health-Related Quality of Life in Patients With Pemphigus.
- Published in:
- Cutis, 2023, v. 111, n. 1, p. 53, doi. 10.12788/cutis.0684
- By:
- Publication type:
- Article
Applicability of glucocorticoid toxicity index in pemphigus: Comparison between two groups of rituximab‐treated and rituximab‐naïve patients.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15902
- By:
- Publication type:
- Article
COVID‐19 vaccines and filler reactions: Should it be considered as a concern?
- Published in:
- Journal of Cosmetic Dermatology, 2022, v. 21, n. 12, p. 6564, doi. 10.1111/jocd.15428
- By:
- Publication type:
- Article
COVID vaccine recommendations in dermatologic patients on immunosuppressive agents: Lessons learned from pandemic.
- Published in:
- Journal of Cosmetic Dermatology, 2022, v. 21, n. 12, p. 6568, doi. 10.1111/jocd.15448
- By:
- Publication type:
- Article
Prevalence and management of chronic hepatitis B in pemphigus and pemphigoid patients: New evidence for the safety of rituximab.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 11, p. 1, doi. 10.1111/dth.15783
- By:
- Publication type:
- Article
Efficacy and safety of oral pioglitazone in the management of lichen planopilaris in comparison with clobetasol: A randomized clinical trial.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 11, p. 1, doi. 10.1111/dth.15868
- By:
- Publication type:
- Article
Assessment of health‐related quality of life in patients with frontal fibrosing alopecia.
- Published in:
- Journal of Cosmetic Dermatology, 2022, v. 21, n. 11, p. 6169, doi. 10.1111/jocd.15183
- By:
- Publication type:
- Article
Botulinum toxin injection as a single or combined treatment with non‐cross‐linked high molecular weight and low molecular weight hyaluronic acid gel for neck rejuvenation: A randomized clinical trial.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15673
- By:
- Publication type:
- Article
Dipeptidyl-Peptidase 4 Inhibitor-Induced Variants of Bullous Pemphigoid: A Case Series of Four Patients.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Adverse outcome and severity of COVID‐19 in patients with autoimmune bullous diseases: A historical cohort study.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 9, p. 1, doi. 10.1111/dth.15672
- By:
- Publication type:
- Article
Coexistence of Pemphigus Vulgaris and Lichen Planus following COVID-19 Vaccination.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Epidemiology, clinical presentation, and management of pemphigoid nodularis: An update from Iran.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15630
- By:
- Publication type:
- Article
Serious health threat of mucormycosis during the ongoing COVID‐19 pandemic: what dermatologists need to know in this regard.
- Published in:
- International Journal of Dermatology, 2022, v. 61, n. 8, p. 979, doi. 10.1111/ijd.16101
- By:
- Publication type:
- Article
Stigma Experience in Patients With Vitiligo: A Comprehensive Study in a Skin Hospital.
- Published in:
- Acta Medica Iranica, 2022, v. 60, n. 7, p. 422
- By:
- Publication type:
- Article
A 10‐year survey on lichen planus pemphigoides in Iran: A therapeutic conundrum.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 7, p. 1, doi. 10.1111/dth.15387
- By:
- Publication type:
- Article
Dexamethasone or prednisone: Which one should be the corticosteroid of choice in patients with pemphigus vulgaris?
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 7, p. 1, doi. 10.1111/dth.15511
- By:
- Publication type:
- Article
The role of SARS‐CoV‐2 infection and its vaccines in various types of hair loss.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 6, p. 1, doi. 10.1111/dth.15433
- By:
- Publication type:
- Article
Retrospective study of gingival involvement in pemphigus: A difficult to treat phenomenon.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 6, p. 1, doi. 10.1111/dth.15475
- By:
- Publication type:
- Article
SARS‐CoV‐2 vaccination and practical points in psoriasis patients: A narrative review.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 5, p. 1, doi. 10.1111/dth.15430
- By:
- Publication type:
- Article
Morphea in two patients after being infected to and being vaccinated against SARS‐CoV‐2 infection.
- Published in:
- Clinical Case Reports, 2022, v. 10, n. 4, p. 1, doi. 10.1002/ccr3.5667
- By:
- Publication type:
- Article
Pemphigus patients with initial negative levels of anti‐desmoglein: A subtype with different profile?
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 4, p. 1, doi. 10.1111/dth.15299
- By:
- Publication type:
- Article
Dramatic resolution of cutaneous lymphoid hyperplasia after receiving intravenous immunoglobulin for COVID‐19.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 4, p. 1, doi. 10.1111/dth.15347
- By:
- Publication type:
- Article
Multiple cycles of rituximab therapy for pemphigus: A group of patients with difficult‐ to‐treat disease or a consequence of late rituximab initiation?
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 2, p. 1, doi. 10.1111/dth.15249
- By:
- Publication type:
- Article
Evaluating the risk‐to‐benefit ratio of using cotrimoxazole as a pneumocystis pneumonia preventative intervention among pemphigus patients treated with rituximab: A retrospective study with 494 patients.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 2, p. 1, doi. 10.1111/dth.15257
- By:
- Publication type:
- Article
COVID vaccination in patients under treatment with rituximab: A presentation of two cases from Iran and a review of the current knowledge with a specific focus on pemphigus.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 1, p. 1, doi. 10.1111/dth.15216
- By:
- Publication type:
- Article
Osteonecrosis of the jaw in a pemphigus vulgaris patient induced by long‐term use of bisphosphonates: A case report and review of the literature.
- Published in:
- Dermatologic Therapy, 2021, v. 34, n. 6, p. 1, doi. 10.1111/dth.15158
- By:
- Publication type:
- Article
COVID‐19 infection risk in patients on immunosuppressive/immunomodulator therapy: A single center study.
- Published in:
- Dermatologic Therapy, 2021, v. 34, n. 6, p. 1, doi. 10.1111/dth.15126
- By:
- Publication type:
- Article